FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W7883948> ?p ?o ?g. }

• W7883948 endingPage "361" @default.
• W7883948 startingPage "353" @default.
• W7883948 abstract "To determine the efficacy and toxicity of higher dose versus standard dose intravenous methotrexate (MTX) and pulses of high-dose cytosine arabinoside with asparaginase versus standard dose cytosine arabinoside and teniposide during intensified continuation therapy for higher risk pediatric B-precursor acute lymphoblastic leukemia (ALL).From 1994 to 1999, the Pediatric Oncology Group conducted a randomized phase III clinical trial in higher risk pediatric B-precursor ALL. A total of 784 patients were randomized in a 2×2 factorial design to receive MTX 1 g/m versus 2.5 g/m and to cytosine arabinoside/teniposide versus high-dose cytosine arabinoside/asparaginase during intensified continuation therapy.Patients receiving standard dose MTX had a 5-year disease-free survival (DFS) of 71.8±2.4%; patients receiving higher dose MTX had a 5-year DFS of 71.7±2.4% (P=0.55). Outcomes on cytosine arabinoside/teniposide (DFS of 70.4±2.4) were similar to higher dose cytosine arabinoside/asparaginase (DFS of 73.1±2.3%) (P=0.41). Overall survival rates were not different between MTX doses or cytosine arabinoside/teniposide versus cytosine arabinoside/asparaginase.Increasing MTX dosing to 2.5 g/m did not improve outcomes in higher risk pediatric B-precursor ALL. Giving high-dose cytarabine and asparaginase pulses instead of standard dose cytarabine and teniposide produced nonsignificant differences in outcomes, allowing for teniposide to be removed from ALL therapy." @default.
• W7883948 created "2016-06-24" @default.
• W7883948 creator A5029474557 @default.
• W7883948 creator A5036295405 @default.
• W7883948 creator A5039534762 @default.
• W7883948 creator A5042596874 @default.
• W7883948 creator A5045136154 @default.
• W7883948 creator A5046874953 @default.
• W7883948 creator A5056916024 @default.
• W7883948 creator A5060384074 @default.
• W7883948 creator A5071056027 @default.
• W7883948 creator A5073833224 @default.
• W7883948 creator A5085010022 @default.
• W7883948 creator A5085491683 @default.
• W7883948 date "2014-07-01" @default.
• W7883948 modified "2023-10-04" @default.
• W7883948 title "Dose Intensification of Methotrexate and Cytarabine During Intensified Continuation Chemotherapy for High-risk B-Precursor Acute Lymphoblastic Leukemia" @default.
• W7883948 cites W2073140442 @default.
• W7883948 cites W2105435030 @default.
• W7883948 cites W2187668060 @default.
• W7883948 cites W2752320641 @default.
• W7883948 doi "https://doi.org/10.1097/mph.0000000000000131" @default.
• W7883948 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4120865" @default.
• W7883948 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24608079" @default.
• W7883948 hasPublicationYear "2014" @default.
• W7883948 type Work @default.
• W7883948 sameAs 7883948 @default.
• W7883948 citedByCount "8" @default.
• W7883948 countsByYear W78839482014 @default.
• W7883948 countsByYear W78839482016 @default.
• W7883948 countsByYear W78839482017 @default.
• W7883948 countsByYear W78839482019 @default.
• W7883948 countsByYear W78839482020 @default.
• W7883948 countsByYear W78839482021 @default.
• W7883948 crossrefType "journal-article" @default.
• W7883948 hasAuthorship W7883948A5029474557 @default.
• W7883948 hasAuthorship W7883948A5036295405 @default.
• W7883948 hasAuthorship W7883948A5039534762 @default.
• W7883948 hasAuthorship W7883948A5042596874 @default.
• W7883948 hasAuthorship W7883948A5045136154 @default.
• W7883948 hasAuthorship W7883948A5046874953 @default.
• W7883948 hasAuthorship W7883948A5056916024 @default.
• W7883948 hasAuthorship W7883948A5060384074 @default.
• W7883948 hasAuthorship W7883948A5071056027 @default.
• W7883948 hasAuthorship W7883948A5073833224 @default.
• W7883948 hasAuthorship W7883948A5085010022 @default.
• W7883948 hasAuthorship W7883948A5085491683 @default.
• W7883948 hasBestOaLocation W78839482 @default.
• W7883948 hasConcept C126322002 @default.
• W7883948 hasConcept C143998085 @default.
• W7883948 hasConcept C2776023528 @default.
• W7883948 hasConcept C2776694085 @default.
• W7883948 hasConcept C2778041864 @default.
• W7883948 hasConcept C2778119113 @default.
• W7883948 hasConcept C2778397455 @default.
• W7883948 hasConcept C2778707968 @default.
• W7883948 hasConcept C2781059491 @default.
• W7883948 hasConcept C54355233 @default.
• W7883948 hasConcept C552990157 @default.
• W7883948 hasConcept C71924100 @default.
• W7883948 hasConcept C86803240 @default.
• W7883948 hasConcept C90924648 @default.
• W7883948 hasConcept C98274493 @default.
• W7883948 hasConceptScore W7883948C126322002 @default.
• W7883948 hasConceptScore W7883948C143998085 @default.
• W7883948 hasConceptScore W7883948C2776023528 @default.
• W7883948 hasConceptScore W7883948C2776694085 @default.
• W7883948 hasConceptScore W7883948C2778041864 @default.
• W7883948 hasConceptScore W7883948C2778119113 @default.
• W7883948 hasConceptScore W7883948C2778397455 @default.
• W7883948 hasConceptScore W7883948C2778707968 @default.
• W7883948 hasConceptScore W7883948C2781059491 @default.
• W7883948 hasConceptScore W7883948C54355233 @default.
• W7883948 hasConceptScore W7883948C552990157 @default.
• W7883948 hasConceptScore W7883948C71924100 @default.
• W7883948 hasConceptScore W7883948C86803240 @default.
• W7883948 hasConceptScore W7883948C90924648 @default.
• W7883948 hasConceptScore W7883948C98274493 @default.
• W7883948 hasIssue "5" @default.
• W7883948 hasLocation W78839481 @default.
• W7883948 hasLocation W78839482 @default.
• W7883948 hasLocation W78839483 @default.
• W7883948 hasLocation W78839484 @default.
• W7883948 hasOpenAccess W7883948 @default.
• W7883948 hasPrimaryLocation W78839481 @default.
• W7883948 hasRelatedWork W147492690 @default.
• W7883948 hasRelatedWork W1991042431 @default.
• W7883948 hasRelatedWork W2012353841 @default.
• W7883948 hasRelatedWork W2030786393 @default.
• W7883948 hasRelatedWork W2060722480 @default.
• W7883948 hasRelatedWork W2089800013 @default.
• W7883948 hasRelatedWork W2252336101 @default.
• W7883948 hasRelatedWork W2410917181 @default.
• W7883948 hasRelatedWork W7883948 @default.
• W7883948 hasRelatedWork W2413788036 @default.
• W7883948 hasVolume "36" @default.
• W7883948 isParatext "false" @default.
• W7883948 isRetracted "false" @default.

• next